Noradrenergic neuromodulation of human attention for emotional and neutral stimuli

Psychopharmacology (Berl). 2008 Mar;197(1):127-36. doi: 10.1007/s00213-007-1015-5. Epub 2007 Nov 30.

Abstract

Introduction: Norepinephrine (NE) has a regulatory role in human attention.

Objective: To examine its role in emotional modulation of attention, we used an attentional blink (AB) paradigm, in the context of psychopharmacological manipulation, where targets were either emotional or neutral items.

Results and discussion: We report behavioural evidence that beta-adrenergic blockade with propranolol impairs attention independent of target valence. Furthermore, this effect is centrally mediated as administration of the peripheral beta-adrenergic antagonist nadolol did not impair attention. By contrast, increasing NE tone, using the selective NE reuptake inhibitor reboxetine, improves detection of emotional stimuli.

Conclusion: In line with theoretical and animal models, these findings provide human behavioural evidence that the adrenergic system has a modulatory influence on selective attention that in some instances depends on item valence.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Uptake Inhibitors / pharmacology
  • Adrenergic beta-Antagonists / pharmacology
  • Adult
  • Arousal / drug effects
  • Arousal / physiology
  • Attention / drug effects
  • Attention / physiology*
  • Attentional Blink / drug effects
  • Attentional Blink / physiology*
  • Brain / drug effects
  • Brain / physiology
  • Color Perception / drug effects
  • Color Perception / physiology
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Emotions / drug effects
  • Emotions / physiology*
  • Female
  • Humans
  • Male
  • Morpholines / pharmacology
  • Nadolol / pharmacology
  • Norepinephrine / physiology*
  • Pattern Recognition, Visual / drug effects
  • Pattern Recognition, Visual / physiology
  • Propranolol / pharmacology
  • Reboxetine
  • Semantics

Substances

  • Adrenergic Uptake Inhibitors
  • Adrenergic beta-Antagonists
  • Morpholines
  • Nadolol
  • Reboxetine
  • Propranolol
  • Norepinephrine